Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

American Journal of Psychiatry

Volumn 157, Issue 9, 2000, Pages 1429-1435

  Bauer, M ^a   Bschor, T ^a   Kunz, D ^a   Berghofer, A ^a   Strohle, A ^a   Muller Oerlinghausen, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DIBENZEPIN; IMIPRAMINE; LITHIUM; MAPROTILINE; NORTRIPTYLINE; PAROXETINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; REMISSION;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0033855704     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.9.1429     Document Type: Article

References (44)

1. Treatment-resistant depression: Definition and treatment approaches
2. The clinical meaning of refractory depression: A review for the clinician
3. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders
4. The combined use of lithium and SSRIs
5. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: A clinical, pharmacokinetic, and pharmacogenetic investigation
6. Combined treatment strategies in psychiatry
7. The use of lithium to augment antidepressant medication
8. Augmentation strategies in patients with refractory depression
9. Treatment options for refractory depression
10. Lithium carbonate augmentation of antidepressant treatment
11. The benefit of lithium carbonate adjunct in refractory depression - Fact or fiction?
12. Adjunct low dose lithium carbonate in treatment-resistant depression: A placebo-controlled study
13. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: Results of a placebo-controlled double-blind study
14. Lithium as an adjunct in the treatment of major depression
15. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
16. Lithium augmentation therapy in tricyclic-resistant depression: A controlled trial using lithium in low and normal doses
17. Placebo-controlled trial of lithium augmentation of fluoxetine and Iofepramine
18. Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies
19. After lithium augmentation: A retrospective follow-up of patients with antidepressant-refractory depression
20. Efficacy of continuation drug therapy of depression and anxiety: Issues and methodologies
21. Recent developments in the pharmacotherapy of mood disorders
22. A rating scale for depression
23. Current trends of research on antidepressive treatment and prophylaxis
24. Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients
25. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale
26. Conceptualization and rational for consensus definitions of terms in major depressive disorder
27. The course of affective disorders, I: Change of diagnosis of monopolar, unipolar, and bipolar illness
28. Initial 6-month follow-up of patients with major depressive disorder: A preliminary report from the NIMH collaborative study of the psychobiology of depression
29. Recovery from major depression: A 10-year prospective follow-up across multiple episodes
30. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness
31. Continuation therapy with amitriptyline in depression
32. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: A randomized, double-blind, controlled trial
33. Continuation drug therapy for major depressive episodes: How long should it be maintained?
34. Experimental withdrawal of lithium in recovered manic-depressive patients: A report of five patients
35. Rapid recurrence of mania following lithium withdrawal
36. Abrupt lithium discontinuation in manic-depressive patients
37. Recurrence of affective illness after withdrawal of long-term lithium treatment
38. Has the time come to abandon prophylactic lithium treatment? a review for clinicians
39. Management of recurrent depression